malondialdehyde has been researched along with Common Bile Duct Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, S; Bukan, N; Dinçer, S; Engin, A; Ercan, SZ; Memiş, L | 1 |
| Feierl, G; Höllwarth, ME; Pesendorfer, P; Ratschek, M; Schimpl, G; Steinwender, G | 1 |
2 other study(ies) available for malondialdehyde and Common Bile Duct Diseases
| Article | Year |
|---|---|
Regulation of fibrogenesis during the early phase of common bile duct obstruction.
Topics: Animals; Cell Proliferation; Cholestasis; Collagen; Common Bile Duct Diseases; Dinoprostone; Disease Models, Animal; Disease Progression; Guinea Pigs; Leukotriene C4; Liver; Liver Cirrhosis; Male; Malondialdehyde; Nitrates; Nitrites | 2006 |
Allopurinol reduces bacterial translocation, intestinal mucosal lipid peroxidation, and neutrophil-derived myeloperoxidase activity in chronic portal hypertensive and common bile duct-ligated growing rats.
Topics: Allopurinol; Animals; Bacterial Translocation; Common Bile Duct Diseases; Constriction; Enzyme Inhibitors; Hypertension, Portal; Intestinal Mucosa; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Peroxidase; Rats; Rats, Sprague-Dawley; Xanthine Oxidase | 1996 |